In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Zimmer Biomet Holdings, Inc.

http://www.zimmerbiomet.com/

Latest From Zimmer Biomet Holdings, Inc.

Minute Insight: Zimmer Biomet Adds Biointegrative Repair Products With Embody Acquisition

Zimmer Biomet reached a definitive agreement to acquire Embody for $155m at closing and up to $120m in future milestones. Embody is a privately held Virginia-based developer of collagen-based bio-fabrication techniques and products for sports medicine applications.

Minute Insights M & A

Deal Watch: Merck KGaA Teams Up With Mersana On STING Agonist ADCs

Mersana signs its third ADC partnership with big pharmas for the year with Merck agreement. Lilly expands its RNA editing partnership with ProQR, which now has the potential to earn an additional $2.5bn. Novartis continues its divestment efforts in deals with Harrow, Erasca.

Deal Watch Business Strategies

Medtech 100: Big Three Companies Lead From The Front With Medtech Back On Solid Growth Footing

Abbott Laboratories and Johnson & Johnson joined Medtronic in putting a clear distance between themselves and other global medtechs in the Top 10 by revenues for 2021. Post-COVID-19 procedure growth, and, for Abbott, a strong rebound in non-COVID diagnostic demand, were key drivers.

Medtech 100 Commercial

Big Three Lead From The Front With Medtech Back On Solid Growth Footing

Abbott Laboratories and Johnson & Johnson joined Medtronic in putting a clear distance between themselves and other global medtechs in the Top 10 by revenues for 2021. Post-COVID-19 procedure growth, and, for Abbott, a strong rebound in non-COVID diagnostic demand, were key drivers.

Outlook 2023 Sales & Earnings
See All

Company Information

  • Industry
  • Biotechnology
  • Medical Devices
  • Medical Devices
    • Biomaterials
    • Implantable Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
      • Surgical Sealants
  • Other Names / Subsidiaries
    • Abbot Spine
    • Biomet, Inc.
    • Arthrotek, Inc.
    • Biomet Biologics, Inc.
    • Cayenne Medical, Inc.
    • CD Diagnostics
    • Clinical Graphics, B.V.
    • Dornoch Medical Systems
    • Etex corporation
    • Implex Corp.
    • Knee Creations LLC
    • LDR Holding Corporation
    • NORMED Medizin-Technik GmbH
    • Quantic Biomedical
    • Ortho Transmission, LLC
    • Zimmer Holdings, Inc.
    • A&E Medical Corp.
UsernamePublicRestriction

Register